MADISON, WI--(Marketwire -02/06/12)- Novelos Therapeutics, Inc. (OTC.BB: NVLT.OB - News), a pharmaceutical company developing novel drugs for treatment and diagnosis of cancer, today announced that Harry S. Palmin, President and CEO of Novelos, will present a corporate update at the 14th Annual BIO CEO & Investor Conference on Monday, February 13, 2012. Mr. Palmin is scheduled to present at 4pm EST in the Duke of Windsor Suite on the 4th floor. The event will be held February 13-14 at The Waldorf Astoria in New York City.

A live webcast of the Novelos presentation may be accessed via http://www.novelos.com
The webcast will be archived for 90 days following the presentation.

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Information about the conference is available at http://www.bio.org/events/conferences/14th-annual-bio-ceo-investor-conference

About Novelos Therapeutics, Inc.
We are a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer. Our three cancer-targeted compounds are selectively taken up and retained in cancer cells (including cancer stem cells) versus normal cells. Thus, our therapeutic compounds appear to directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy versus all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. LIGHT is a small-molecule cancer-targeted PET imaging agent. We believe LIGHT has first-in-class potential and Phase 1-2 clinical trials are ongoing. HOT is a small-molecule, broad-spectrum, cancer-targeted molecular radiotherapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. We believe HOT also has first-in-class potential. HOT Phase 1b dose-escalation trial is ongoing and we expect HOT to enter Phase 2 trials in the first quarter of 2013 as monotherapy for solid tumors with significant unmet medical need. COLD, a cancer-targeted non-radioactive chemotherapy, works primarily through Akt inhibition. We plan to file an IND for COLD in the first quarter of 2013. Together, we believe our compounds are able to "find, treat and follow" cancer anywhere in the body in a novel, effective and highly selective way. For additional information please visit http://www.novelos.com

This news release contains forward-looking statements. You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates. Such statements are valid only as of today, and we disclaim any obligation to update this information. These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involve a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement.

Continued here:
Novelos Therapeutics to Present at the 14th Annual Bio CEO & Investor Conference on February 13

Do you remember when we used to think some things were impossible? Modern technology has taught us to never say never or impossible. I think about the 1970s and 1980s growing up without cell phones, computers and many of the electronically advanced gadgets that our kids today take for granted. I can’t even imagine what the great innovators will come up with next.

When I was a young child, I remember watching science fiction movies about cloning people and remember how obscure and unbelievable it seemed at the time. It was common knowledge that cloning was strictly science fiction. Now, cloning is not only possible, but a procedure that has occurred with astonishing success. Fortunately, cloning has only been performed with animals and not yet humans.

Medically speaking, one of the most popular and potentially one of the most substantial advances in modern medicine is stem cell research and therapy. Initially, stem cell research was met with a great deal of resistance and controversy. The reason stem cell research had trouble getting started was because stem cells could only be collected from fetuses. With time, scientists have successfully harvested stem cells from other sources.

Stem cells are primitive or extremely young cells which are capable of dividing and changing into a variety of cell types. They have the ability to develop into cells that form muscle, cartilage, bone or other tissues. One of the remarkable findings about stem cells is that they seem to detect and “know” which tissue is damaged and automatically change into the cells needing repaired.

In actuality, the damaged tissue sends some type of signal to the stem cells allowing them to respond and promote healing of the injured tissues. Essentially, stem cells have the ability to grow into mature tissue cells wherever they are needed and this makes them very useful for repairing certain body tissues damaged by injury, disease and possibly aging.

Stem cell treatment is a type of medical therapy called regenerative medicine. Regenerative medicine is simply a category of medical therapy pertaining to growing new tissue. Although stem cell therapy is an extremely unique and obviously beneficial type of medical treatment, it is also a very vast field of medical research and certainly has not been completely perfected. There are countless possibilities and applications for stem cell therapy and medical researchers have barely scratched the surface with regards to stem cell potential.

Until now the gold standard for treating arthritis in pets has been to give them anti-inflammatory medications, joint supplements and sometimes acupuncture. Over the years, these types of medications have improved greatly and pets have benefitted wonderfully from receiving this kind of treatment. However, even with the improvements, these medications have potential side effects. Sometimes, the side effects may even outweigh the benefits, depending on the individual circumstance.

Therefore, stem cell therapy offers treatment that doesn’t just relieve the symptoms, but actually regenerates or grows new tissue allowing for complete healing and without side effects. Presently, there are some stem cell applications already being used in veterinary medicine!

Recently, veterinary specialists have developed a technique for collecting stem cells from fat tissue and administering the stem cells into dogs, cats and horses specifically for treatment of arthritis. The process involves collecting a small amount of fat from the patient and then the fat is placed into a machine which extracts and concentrates stem cells. Next, the stem cells are injected back into the patient’s joints forthe treatment of arthritis.

There is a certain protocol for proceeding with the stem cell therapy. First, a definitive diagnosis of arthritis, using X-rays, must be made by your veterinarian. Additionally, your pet would need a complete workup including blood tests and additional X-rays to rule out any other disease processes such as infection or cancer. Any patient with cancer would not be a good candidate for stem cell therapy and any infection would need to be cleared prior to stem cell therapy.

Following the initial workup, your pet would be sedated or anesthetized for surgical collection of fat tissue. The fat tissue would then be sent to a lab to have the stem cells extracted and processed from the fat. Then, your pet would need to be sedated again to administer the injections containing the stem cells into their arthritic joints.

In pets, stem cell therapy is primarily available and being used for arthritis. However, I have no doubt that it won’t be long before stem cell therapy will be used in pets to treat many diseases and conditions. It has already shown to be effective for diabetes, allergies, gastrointestinal diseases, pancreatitis and many other diseases.

If you have a pet that you think might be suffering from arthritis, contact your veterinarian as soon as possible to consider stem cell therapy and to ensure your pet lives a long, healthy and happy life.

Excerpt from:
The Pet Corner: Behold! The future of modern medicine is here

Home > News > health-news

Washington, Jan 10 : Stem cells of cord blood can be used to treat Type 1 diabetes, a new study has revealed.

Type 1 diabetes is caused by the body's own immune system attacking its pancreatic islet beta cells and requires daily injections of insulin to regulate the patient's blood glucose levels.

A new method described in the new study uses stem cells from cord blood (blood that remains in the placenta and in the attached umbilical cord after childbirth) to re-educate a diabetic's own T cells and consequently restart pancreatic function reducing the need for insulin.

Stem Cell Educator therapy slowly passes lymphocytes separated from a patient's blood over immobilized cord blood stem cells (CBSC) from healthy donors.

After two to three hours in the device the re-educated lymphocytes are returned to the patient.

The progress of the patients was checked at 4, 12, 24 and 40 weeks after therapy.

C-peptide is a protein fragment made as a by-product of insulin manufacture and can be used to determine how well beta cells are working.

By 12 weeks after treatment all the patients who received the therapy had improved levels of C ?peptide. This continued to improve at 24 weeks and was maintained to the end of the study.

This meant that the daily dose of insulin required to maintain their blood glucose levels could be reduced. In accordance with these results the glycated hemoglobin (HbA1C) indicator of long term glucose control also dropped for people receiving the treatment, but not the control group.

"We also saw an improved autoimmune control in these patients," Dr Yong Zhao, from University of Illinois at Chicago, who led the multi-centre research, said.

Stem Cell Educator therapy increased the percentage of regulatory T lymphocytes in the blood of people in the treatment group. Other markers of immune function, such as TGF-beta1 also improved.

The study has been published in BioMed Central's open access journal BMC Medicine. (ANI)

Share this article at

Yearly Horoscope of 2012 for the Zodiac Sign:

Sagittarius     Scorpio     Libra    Virgo    Leo     Cancer     Gemini     Taurus     Aries     Pisces     Aquarius     Capricon

TOP READ ARTICLES:

Gary Glitter could earn thousands of pounds from Super Bowl royalties
Keira Knightley overcame dyslexia by reading Emma Thompson's film script
Demi Lovato says she lacks confidence to face camera
Demi Moore taking 'spiritual counselling' after hospitalisation
Tilda Swinton lets her friends choose her red carpet dresses
Nicola Roberts furious over Girls Aloud break
Rooney Mara to star in 'Side Effects'
Reese Witherspoon impressed with Robert Pattinson
Simon Cowell to air backstage drama on 'Britain's Got Talent'
Patrick Stewart regrets putting career over family
Rachel McAdams shocked by Tatum's fake penis
Cynthia Nixon clarifies remark about being gay by choice
George Clooney said 'I Love You' to Mary Tyler Moore
Elton John advises Madonna to 'lip-synch good' at Super Bowl gig
'The Artist' dog star Uggie to retire from films

More here:
Stem cell treatment may help reverse diabetes

See the article here:
Vet-Stem Announces Milestone of 8,000 Animals Treated With Vet-Stem Cell Therapy

23-12-2011 09:16 http://www.franchise.com presents - Medivet America Pet Franchise provides innovative, and now affordable, therapy for pets suffering from conditions like arthritis. Using stem cell regenerative therapy treatment Medivet is able to using stem cells, meant for repairing the body, to target and treat your pets conditions. veterinarian

Go here to see the original:
Medivet America Pet - Video

13-12-2011 22:16 Dr. Marta Sanchez, Animal Health

See original here:
Stemcell therapy for pets - Mi Mascota - Video

This is a story that Fox 35 Orlando did on Val-U-Vet and Stem Cell Therapy. Go to http://www.valuvet.com for more info.

More here:
Amazing Stem Cell Therapy Results | Before

This is a compilation of a commercial teaser and two separate stories that Local 6 did on Val-U-Vet and Stem Cell Therapy. Go to http://www.valuvet.com for more info.

Continue reading here:
Two Different Local 6 News Stories on Val-U-Vet Stem Cell Therapy Results - Video

Stem Cell Clinic Publishes First Peer Reviewed Paper on Autism Stem Cell Therapy

Follow this link:
Stem Cell Therapy for Autism: A Proposal - Video

Riot's palpation examination showing major improvement just two weeks after the Adipose Stem Cell Therapy he received at University Animal Hospital in Greensboro, NC.

Go here to read the rest:
Riot's Lameness Palpation Exam - 2 weeks post Adipose Stem Cell Therapy - Video